Company news
Trailbreaker Resources Ltd news in 2006
Trailbreaker Resources Ltd's news releases, calls and decks from 2006, newest first.
Market Regulation Services - Trade Resumption - Axcan Pharma Inc. - AXP
September 29, 2006
Market Regulation Services - Trading Halt - Axcan Pharma Inc. - AXP
September 29, 2006
Conclusion of an agreement in principle with respect to a qualifying transaction between DCB Capital Inc. and Opsens Inc.
July 12, 2006
Axcan Pharma appoints new Senior Vice President and Chief Scientific Officer
May 10, 2006
Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006
May 4, 2006
Axcan Pharma's President and CEO to provide Keynote Luncheon Speech at AMBAQ's Annual MBA Conference April 27, 2006
April 26, 2006
Axcan announces conference call and web cast for second quarter of fiscal 2006 results
April 24, 2006
Axcan Pharma to present at the Scotia Capital Pharmaceutical & Biotechnology Conference
April 19, 2006
Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference
April 18, 2006
Axcan submits FDA amendment to its new drug application for HELIZIDE
March 29, 2006
Axcan Pharma to present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
March 28, 2006
Axcan announces outcome of ITAX International Phase III clinical trial
February 22, 2006
Axcan Pharma to hold Annual and Special Meeting of Shareholders February 22, 2006
February 20, 2006
Axcan announces conference call on statistical approach for Phase III trials of ITAX
February 13, 2006
Axcan announces record revenue of $70.6 million for the first quarter of fiscal 2006
February 9, 2006
Axcan Pharma to present at CIBC's Institutional Investor Conference
February 8, 2006
Axcan announces conference call and web cast for first quarter of fiscal 2006 results
February 2, 2006
Axcan Pharma to present at Merrill Lynch Global Healthcare Conference
January 31, 2006
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
January 20, 2006
Axcan Pharma to present at JP Morgan's Healthcare Conference
January 4, 2006